Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 31,449
  • Shares Outstanding, K 88,440
  • Annual Sales, $ 0 K
  • Annual Income, $ -120 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/21/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2895 +15.54%
on 08/30/18
0.4199 -20.34%
on 08/27/18
-0.0505 (-13.12%)
since 08/17/18
3-Month
0.0910 +267.58%
on 08/08/18
0.4996 -33.05%
on 08/09/18
-0.0156 (-4.46%)
since 06/19/18
52-Week
0.0910 +267.58%
on 08/08/18
2.4600 -86.40%
on 12/29/17
+0.1845 (+123.00%)
since 09/19/17

Most Recent Stories

More News
Pivot Appoints Dr. Joseph Borovsky as Chairman of Board of Directors Formerly Director of R & D of The Mead Corporation

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that Dr. Joseph Borovsky has been appointed as Chairman of the Board of Directors of...

PVOTF : 0.3345 (-5.93%)
PVOT.CN : 0.435 (-8.42%)
Pivot Monetizes "RTIC" Technology And Enters Nevada Cannabis Market With Strategic Partner

Transaction Includes Licensing, Manufacturing, Co-marketing and Distribution Agreements

PVOTF : 0.3345 (-5.93%)
Pivot Acquires Rights To Patented Solumer™ Oral Drug Delivery Technology Ideal For Use In Cannabis-Infused Beverage Formulations

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Definitive Agreement with Israeli-based SoluBest Ltd. to acquire...

PVOTF : 0.3345 (-5.93%)
Pivot Acquires Rights To Patented Solumer™ Oral Drug Delivery Technology Ideal For Use In Cannabis-Infused Beverage Formulations

VANCOUVER , Aug. 7, 2018 /PRNewswire/ - Pivot Pharmaceuticals Inc . (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT ) ("Pivot" or the "Company") is pleased to announce that it has signed a...

PVOTF : 0.3345 (-5.93%)
Pivot Signs Exclusive Co-Marketing And Distribution Agreement with Swiss-based S.T.U. GmbH, Establishes Large Retail and Online Sales Channels In The European Union

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has entered into a Definitive Co-marketing and Distribution Agreement ("the Agreement")...

PVOTF : 0.3345 (-5.93%)
Pivot Pharma To File Investigational New Drug (IND) Application With U.S. FDA For PVT-005

Cannabinoid Topical Cream For Treatment Of Female Hypoactive Sexual Desire Disorder

PVOTF : 0.3345 (-5.93%)
Pivot Pharma To File Investigational New Drug (IND) Application With U.S. FDA For PVT-005

Cannabinoid Topical Cream For Treatment Of Female Hypoactive Sexual Desire Disorder

PVOTF : 0.3345 (-5.93%)
Pivot Signs Manufacturing and Supply Agreement With California-Based Stoney LLC

RTIC Powderized Products Including Capsules and Edibles To Generate Sales In California

PVOTF : 0.3345 (-5.93%)
Pivot Provides Shareholder Update

Pivot Provides Shareholder Update

PVOTF : 0.3345 (-5.93%)
Pivot Pharmaceuticals Terminates Letter of Intent for the Acquisition of Agro-Biotech

VANCOUVER , April 16, 2018 /PRNewswire/ - Pivot Pharmaceuticals Inc . (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT ) ("Pivot" or the "Company") reports that it has terminated the previously...

PVOTF : 0.3345 (-5.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade PVOTF with:

Key Turning Points

2nd Resistance Point 0.3851
1st Resistance Point 0.3703
Last Price 0.3345
1st Support Level 0.3286
2nd Support Level 0.3017

See More

52-Week High 2.4600
Fibonacci 61.8% 1.5550
Fibonacci 50% 1.2755
Fibonacci 38.2% 0.9960
Last Price 0.3345
52-Week Low 0.0910

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar